<DOC>
	<DOCNO>NCT01906073</DOCNO>
	<brief_summary>Today , patient cancer pain need opioids moderate severe pain get long-acting morphine twice day morphine tablet take demand addition . This procedure might base assumption cancer pain persistent , although evidence support whether assumption applies cancer patient lack . Some cancer patient might need fix dose long-acting morphine . Because rapid pain relief , new fentanyl drug open possibility take opioid demand pain occur . A pilot study 10 patient cancer pain treat rapid-acting fentanyl nasal spray take demand , show treatment apparently feasible safe patient . This approach study NFCP-II . The participant treat rapid-acting fentanyl nasal spray long-acting morphine crossover study . The primary outcome patient satisfaction . The study consist test dose nasal fentanyl , dose-finding phase treatment phase either nasal fentanyl take demand slow-released morphine take twice day . After 10 day treatment crossover opposite drug use participant . Morphine tablets take demand phase study . The participant meet investigator inclusion , crossover end treatment . During study , diary fill participant every morning . Questions pain side effect answer . Satisfaction measure crossover end treatment preference measure end treatment .</brief_summary>
	<brief_title>Nasal Fentanyl Chronic Cancer Pain</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>1 . Cancer disease 2 . Adult ( old 18 year ) 3 . Cancerrelated pain &gt; 4 11 point Numerical Rating Scale ( NRS ) 4 . In need opioids ( step II III ) 5 . Able use nasal drug . 6 . Life expectancy &gt; 6 month 7 . Karnofsky status &gt; = 60 8 . Women child bear potential must use adequate contraception 9 . Informed consent give accord applicable requirement trialrelated activity . 1 . Use opioids moderate severe pain 2 . History substance abuse . * 3 . Pathological condition nasal cavity contraindication nasal fentanyl 4 . Renal liver failure , define creatinin &gt; 150 alanineamino transferase ( ALAT ) &gt; x 1.5 reference value 5 . Sleep apnoea syndrome , severe chronic obstructive lung disease illnesses lead severe respiratory depression . 6 . Psychiatric disease 7 . Neurological disease give dizziness sedation 8 . Cognitive impairment make patient unable complete questionnaire able comply study procedure . 9 . Previous ongoing facial radiotherapy 10 . Recurrent nose bleed 11 . Known hypersensitivity active substance excipients study drug 12 . Pregnant breastfeed woman 13 . Treated monoamine oxidase ( MAO ) inhibitor within last 14 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>fentanyl</keyword>
	<keyword>administration , intranasal</keyword>
	<keyword>morphine</keyword>
	<keyword>patient satisfaction</keyword>
	<keyword>patient preference</keyword>
</DOC>